(Total Views: 852)
Posted On: 03/03/2021 8:26:55 AM
Post# of 148884
My thoughts on this:
a) Mahboob U. Rahman, M.D., Ph.D., FACR and all the other physicians who work for CYDY are not stupid, even in the USA you can not order your doctorate from Amazon
b) DSMC not stupid
c) AMAREX not stupid(https://www.amarexus.com/ )
e) FDA not stupid,
look at the drugs that have meanwhile received an EUA with, in my eyes, partly "lean" results of the https://www.fda.gov/emergency-preparedness-an...nse/mcm-... studies
"The FDA is committed to identifying efficient ways to modify medical products that are either in the pipeline or have been authorized for emergency use to address emerging variants," Dr. Janet Woodcock, acting commissioner of the FDA, said in the announcement on Monday. We know the country is eager to return to a new normal and the emergence of the virus variants raises new concerns about the performance of these products," Woodcock said in part. "By issuing these guidances, we want the American public to know that we are using every tool in our toolbox to fight this pandemic, including pivoting as the virus adapts."
https://edition.cnn.com/2021/02/22/health/fda...d-guidan... https://www.fda.gov/news-events/press-announc...coronavi...
The FDA will not decide and approval to have a look only at the endpoint of a study. The FDA will certainly include data from THE CD10, THE OLE and the whole eIND's, if necessary. The FDA, MHRA and Canada will approve Leronlimab. I've finished... Just my opinion.
The FDA knows also the potential danger of this:
https://www.nytimes.com/2021/03/01/health/cov...5f01e70e06
a) Mahboob U. Rahman, M.D., Ph.D., FACR and all the other physicians who work for CYDY are not stupid, even in the USA you can not order your doctorate from Amazon
b) DSMC not stupid
c) AMAREX not stupid(https://www.amarexus.com/ )
e) FDA not stupid,
look at the drugs that have meanwhile received an EUA with, in my eyes, partly "lean" results of the https://www.fda.gov/emergency-preparedness-an...nse/mcm-... studies
"The FDA is committed to identifying efficient ways to modify medical products that are either in the pipeline or have been authorized for emergency use to address emerging variants," Dr. Janet Woodcock, acting commissioner of the FDA, said in the announcement on Monday. We know the country is eager to return to a new normal and the emergence of the virus variants raises new concerns about the performance of these products," Woodcock said in part. "By issuing these guidances, we want the American public to know that we are using every tool in our toolbox to fight this pandemic, including pivoting as the virus adapts."
https://edition.cnn.com/2021/02/22/health/fda...d-guidan... https://www.fda.gov/news-events/press-announc...coronavi...
The FDA will not decide and approval to have a look only at the endpoint of a study. The FDA will certainly include data from THE CD10, THE OLE and the whole eIND's, if necessary. The FDA, MHRA and Canada will approve Leronlimab. I've finished... Just my opinion.
The FDA knows also the potential danger of this:
https://www.nytimes.com/2021/03/01/health/cov...5f01e70e06
(9)
(0)Scroll down for more posts ▼
